Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
From innovative devices to cutting-edge treatments, various technologies are now employed to aid individuals in their weight loss journey
Retinopathy, neuropathy, and foot care: standards of care in diabetes-2025
On May 1, 2025, Eli Lilly announced that it withdrew its FDA application for Zepbound (tirzepatide) for the treatment of HFpEF in patients with obesity, stating that the FDA requires an additional confirmatory trial to support the application
These results help better understand the role of carnitine on COVID-19, and will facilitate therapeutic drugs in future clinical trials
US$ 28.25
US$ 26.38
US$ 27.25
US$ 25.87
